Noetik logo

Noetik

Emerging

Noetik raised 2M and signed a 0M GSK licensing deal to build cancer biology foundation models on multi-omic data, uncovering drug targets invisible to conventional tools (2022, SF).

Best for: AI Cancer Biology & Drug DiscoveryEmerging, rapid growth
24
AI Score
Grade D↑ Trending
AI Visibility Score (Beta)
HealthcareAI Cancer Biology & Drug DiscoveryWebsiteUpdated April 2026

Brand Intelligence Graph

Capabilities
AI Cancer Biology & Drug Discovery

Company Overview

About Noetik

Noetik is a San Francisco-based AI-native biotechnology company founded in 2022 with the mission of decoding cancer biology at molecular resolution using foundation models trained on multi-omic data. The company was founded on the thesis that the biological complexity underlying cancer — the interactions between tumor cells, the immune system, the tumor microenvironment, and genomic variation — exceeds what human researchers or conventional computational tools can fully model, and that large-scale AI trained on comprehensive biological datasets can discover drug targets and patient stratification strategies that would otherwise remain hidden. Noetik builds cancer biology foundation models that learn the language of cellular systems from massive datasets of genomic, transcriptomic, and proteomic measurements.

Business Model & Competitive Advantage

Noetik's platform applies its foundation models to drug discovery programs, with a focus on identifying novel targets in difficult-to-treat cancers and predicting which patient populations are most likely to respond to specific therapeutic mechanisms. The models are designed to generate hypotheses at a speed and scale that dramatically compresses the early discovery timeline, enabling the company and its partners to explore vastly more biological hypotheses per year than conventional approaches allow. Noetik's scientific platform is built to be partnered as well as proprietary — the company licenses its cancer biology AI capabilities to pharmaceutical companies seeking to accelerate and de-risk their early discovery pipelines.

Competitive Landscape 2025–2026

Noetik has raised $62 million in total funding and secured a $50 million licensing deal with GSK, one of the world's largest pharmaceutical companies, validating both the scientific quality of its foundation models and the commercial interest from major pharma in AI-native biology platforms. The GSK deal provides both capital and a prestigious scientific partnership that elevates Noetik's credibility across the drug discovery ecosystem. As AI biology becomes a defining competitive dimension in pharmaceutical R&D, Noetik's cancer-focused foundation models and demonstrated ability to attract top-tier pharma partnerships position it as an emerging leader in AI-driven oncology drug discovery.

Founded
2022
Curated content • Fact-checked and verified

Recent Activity

View all →

Key Differentiators

Emerging Innovator

Noetik is an emerging player bringing innovative solutions to the Healthcare Tech market.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

24
↑ Trending

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Veeva Systems logo

Veeva Systems

Healthcare Tech
B2bHealthtechSaasPublic

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv

athenahealth logo

athenahealth

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on

Idexx Laboratories logo

Idexx Laboratories

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu

Revvity logo

Revvity

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid

GE HealthCare logo

GE HealthCare

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designin

Incyte logo

Incyte

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company — publicly traded on the NASDAQ (NASDAQ: INCY) as an S&P 500 Health Care component — focused on oncology and inflammation,

Compare Noetik with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Noetik

Claim This Profile

Are you from Noetik? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Noetik Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Noetik vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →